New England’s Top 10 Q2 Venture Deals

Yesterday we told you about the largest second-quarter venture deals in Massachusetts. Today we’re feeling more expansive, so below are the top 10 for New England. (Thanks again to Dow Jones VentureOne for the data, and for double-checking it before we hit the “publish” button.) One thing’s for sure, the Connecticut biomedical scene is bustling.

Sagent Advisors in New York tops the list, raising $52 million from Daiwa Securities in a second round.

—Shelton, CT’s Spine Wave took in $45 million in a fourth round led by Compass Global Fund.

—New Haven, CT-based Applied Spine Technologies raised $28 million in a third round led by Investor Growth Capital.

—Another Connecticut local, New Haven’s BioRelix, closed a $25.75 million first round, led by CHL Medical Partners.

—Tudor Ventures led a fourth round that brought in $25.5 million for TransMedics, in Andover, MA.

—Westford, MA-based VeriVue’s first round, worth $25 million, came from Matrix Partners and Spark Capital.

—New York’s IGA Worldwide took in $25 million in a second round led by KTB Ventures.

—In a fourth-round deal, MooBella, in Taunton, MA, also raised $25 million, from Inventages Venture Capital.

RainDance Technologies of Guilford, CT, closed a $23.66 million first round from Mohr Davidow Ventures.

—Woburn, MA’s BioVex raised $22 million in a later-stage deal led by Triathlon Medical Ventures.

Author: Rebecca Zacks

Rebecca is Xconomy's co-founder. She was previously the managing editor of Physician's First Watch, a daily e-newsletter from the publishers of New England Journal of Medicine. Before helping launch First Watch, she spent a decade covering innovation for Technology Review, Scientific American, and Discover Magazine's TV show. In 2005-2006 she was a Knight Science Journalism Fellow at MIT. Rebecca holds a bachelor's degree in biology from Brown University and a master's in science journalism from Boston University.